Measures in the first year of therapy predict the response to interferon β in MSJordi Río, Xavier Montalbán, Joaquín Castilló et al.|Multiple Sclerosis Journal|2009Cited by 242
Brainstem lesions in clinically isolated syndromesMar Tintoré, Xavier Montalbán, Àlex Rovira et al.|Neurology|2010Cited by 195
Plasma exchange for acute attacks of CNS demyelinationSara Llufriú, Albert Saiz, Joaquim Castilló et al.|Neurology|2009Cited by 190
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changesÁngela Vidal‐Jordana, Xavier Montalbán, Jaume Sastre‐Garriga et al.|Multiple Sclerosis Journal|2013Cited by 102
Clinical impact of early brain atrophy in clinically isolated syndromesFrancisco Pérez‐Miralles, Xavier Montalbán, Jaume Sastre‐Garriga et al.|Multiple Sclerosis Journal|2013Cited by 95